1Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the Women's Health Initiatine randomized controlled trial. JAMA, 2002,288 (3) : 321- 333.
2Reinli K, Block G. Phytoestrogen content of foods - a compendium of literacure values. Nutr cancer, 1996, 26(2) : 123- 148.
3Setchell KD. Absorption and metabolism of soy isoflavone from food to dietary supplement and adults to infants. J Nutr,2000,130(3):654s- 655s.
4Kuiper GG,Carlsson B,Grandien K,et al. Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors alpha and Beta. Endocrinology,1997,138(3):863 - 870.
5Tham DM, Garder CD, Haskell WL, et al. Potential health benefits of dietary phytoestrogen: a view of the clinical,epidemiological and mechanic evidence. Clin Endocrinol Metab,1998,83:22 - 33.
7Wangen KE, Duncan AM, Xu X, et al. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. AM J Nutr,2001,73(2) :225 - 231.
8Sagara M, Kanda T, Jelekera M, et al. Effects of dietary intake of soy protein and isoflavones on cardiovascular disease risk factors in high risk, middle aged men in Scotland. J AM Coll Nutr, 2004,23 (1) : 85 - 90.
9Scheiber MD, Liu JH,Subbian MJ, et al. Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause,2001,8(5) : 384 -392.
10Tomobe K, Diana J. Effect of Dietary soy Protein and Genistein on Disease Progression in Mice with Polycystic Kidney Disease J. Am J Kidney Dis, 1998,31(5) :55 - 61.
二级参考文献30
1Barnes S, Peterson G, Grubbs C, et al. Potential role of dietary isoflavones in the prevention of cancer[J ]. Adv Exp Med Biol, 1994, 354(4) : 135-147.
2Xu X,Harris KS, Wang HJ. Bioavailability of soybean isoflavones deponds upon gut microflora in women[J] .J Nutr, 1995, 125(9) :2307-2315.
3Xu X, Wang HJ, Murphy PA, et al. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women[ J]. J Nutr, 1994,124(6) :825-831.
4Zhang Y, Wang G J, Song TT. Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity [ J ]. J Nutr, 1999, 129 ( 5 ) :957-962.
5Murphy CT, Kellie S, Westwick J. Tyrosine-kinase activity in rabbit platelets stimulated with platelet-activating factor. The effect of inhibiting tyrosine kinase with genistein onplatdet-signal-molecule elevation and functional responses[J]. Eur J Biochem, 1993, 1,216(2) : 639-651.
7Pollard M, Luekert PH. Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rots [ J ].Nutr Cancer, 1997,28 ( 1 ) : 41-45.
8Pereira MA, Barnes LH, Rassman VL, et al. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents[J]. Carcinogenesis, 1994,15(5) : 1049-1054.
9Tomobe K, Diana J. Effect of Dietary Soy Protein and Genistein on Disease Progression in Mice with Polycystic Kidney Disease [ J]. Am J Kidney Dis, 1998,31(5) :55-61.
10Barsotti G, Ciardella F, Morelli E, et al. Nutritional treatment of renal failure in type 1 diabetic nephropathy[J]. Clin Nephrol, 1988,29(6):280-287.
